Last week, I was in a meeting with the sales head of a major pharmaceutical company. As we were discussing sales training during the Covid pandemic, he showed me an internal company WhatsApp group, which included his distributed sales reps. He threw a challenge everyday to them, and the group…
Engaging Doctors – Physical, Digital & Hybrid: Translating Strategy Into Action Keynote Address: Rajaram Narayanan, Managing Director, Sanofi India Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021. Panel Members: Atish Majumdar – President, MankindPharmaPraful Akali – CEO, Medulla CommunicationsShireesh Sahai – CEO, Wolters…
When Covid19 struck for the first time in March 2020, the pharma industry was not ready for the sudden and dramatic changes, that disrupted the healthcare industry completely. And to deal with the sudden and dramatic changes, professionals in the pharma industry needed awareness, education, and knowledge sharing. MedicinMan took up this responsibility…
Pankaj Gurusahani and Arun Subramanian, Co-founder of Enparadigm with Anup Soans, discuss the importance of sales enablement for Medical Reps Watch it Now: https://youtu.be/HDiMTDvZpB0 via YouTube Anup SoansReach out to Anup Soans: anupsoans@medicinman.net or use the social media buttons below. medicinman.net
Challenging times lay ahead for the sales departments in the pharma industry. The COVID-19 pandemic will surely not be the first disruption, as recent geopolitical tensions, and economic turmoil show. Agile and adaptive sales enablement is thus a must-have in the coming months and years.
The Medical department comprising of Clinical Operations (the ones who generate data), Regulatory Affairs (the ones who submit data to the regulator for approval), Medical Affairs (the ones who bring out the value of that data for the customer), Pharmacovigilance (the ones who do benefit to risk evaluation of a…
In the lockdown, while I was on regular OPD and ICU rounds at a COVID hospital, I started noticing some mild symptoms of the Coronavirus infection. Being in the medical field and considering the severity of the pandemic situation then, I was very careful and cautious, and observed the symptoms closely. The symptoms persisted and I had to self-quarantine until the medical test reports came. It was important for me to isolate myself from the rest of the medical team and prevent the spread of the virus. Finally, the report came: I was COVID positive!
Stunned and slightly devastated; I broke the news to my family who could not believe it either. As a doctor, I could only treat, comfort and empathize with the COVID patients undergoing treatment; completely isolated from their loved ones. But now, I could actually feel the uncertainty of the situation. I was hospitalized and continued to experience body-ache during the admission. It was a stressful situation where I felt anxious and stressed about everything.
My CT scan reports showed mild lung infection on the day of admission but as the cytokines storm developed, my lungs were 76 % damaged in 3-5 days and I was short of breath and my oxygen level deteriorated to less than 80. I was shifted to an ICU with high-flow oxygen and was on a BiPap machine which I had purchased a few weeks ago for the hospital and never imagined that I would be using myself one day.
If a business fails, it was an idea that didn’t work. If treatment fails – it must be a botch up. A broken gadget may be beyond repair, but not a patient in a doctor’s hands. From such ungraded expectations stems the potential for things to take an ugly turn.
An unwanted profession dealing with an unwanted condition, namely Ill health:
If possible, we would wish away death and diseases, hospitals and doctors. A hospital is not a holiday resort, but it too costs money. And the scenario of an adverse outcome like death simply becomes unacceptable.
https://www.credoweb.in/discussion/661/new-growth-drivers-for-indian-pharma-companies Ashok Nair began his career as a Medical Rep and rose to become the Managing Director of one of India’s most admired pharma companies – Abbott India. In this conversation, Ashok Nair shares his perspectives on the challenges ahead and what Indian Pharma needs to do, to face them…
9 million people used telemedicine services during the early months of the Covid19 crisis in 2020. $4 billion was billed nationally for telehealth visits during March and April, compared to less than the $60 million for the same two months of 2019. Dr. Shenoy Robinson discussed threadbare all the nitty…